Empowered Funds
TXMD icon

Empowered Funds’s TherapeuticsMD TXMD Stock Holding History

Empowered Funds’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33.9K Buy
+16,705
New +$34.9K ﹤0.01% 2494

Other funds holding TXMD

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Tejara Capital
Tejara Capital London, United Kingdom $205M AUM 0.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Empowered Funds's TXMD Position: Q3 2026 in Review

Empowered Funds opened a new position in TherapeuticsMD (TXMD) in Q3 2026: 16,705 shares worth $33.9K. The stake represents ﹤0.01% of the portfolio and ranks #2494 among its holdings.

36 funds tracked by Wall St. Rank hold TXMD as of Q3 2026.

  • Empowered Funds held 16,705 shares of TherapeuticsMD worth $33.9K as of Q3 2026.
  • TherapeuticsMD was a new Empowered Funds position in Q3 2026.
  • TherapeuticsMD made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2494 holding.
  • 36 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.